๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || A Case Study in Drug Repositioning: Sosei

โœ Scribed by Barratt, Michael J.; Frail, Donald E.


Book ID
121821190
Publisher
John Wiley & Sons, Inc.
Year
2012
Tongue
English
Weight
105 KB
Edition
1
Category
Article
ISBN
0470878274

No coin nor oath required. For personal study only.

โœฆ Synopsis


Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E. Frail And Michael J. Barratt -- Clinical And Operational Considerations In Repositioning Marketed Drugs And Drug Candidates / Damian O'connell, David J. Sequeira, And Maria L.miller -- Regulatory Considerations And Strategies For Drug Repositioning / Ken Phelps -- Computational And Bioinformatic Strategies For Drug Repositioning / Richard Mazzarella And Craig Webb -- Mining Scientific And Clinical Databases To Identify Novel Uses For Existing Drugs / Christos Andronis ... [et Al.] -- Predicting The Polypharmacology Of Drugs : Identifying New Uses Through Chemoinformatics, Structural Informatics, And Molecular Modeling-based Approaches / Li Xie ... [et Al.] -- Systematic Phenotypic Screening For Novel Synergistic Combinations: A New Paradigm For Repositioning Existing Drugs / Margaret S. Lee -- Phenotypic In Vivo Screening To Identify New, Unpredicted Indications For Existing Drugs And Drug Candidates / Michael S. Saporito, Christopher A. Lipinski, And Andrew G. Reaume -- Old Drugs Yield New Discoveries : Examples From The Prodrug, Chiral Switch And Site-selective Deuteration Strategies / Adam J. Morgan ... [et Al.] -- Repurposing Drugs For Tropical Diseases : Case Studies And Open-source Screening Initiatives / Curtis R. Chong -- Drug Repositioning Efforts By Nonprofit Foundations -- Business Development Strategies In The Repositioning Industry / Aris Persidis And Elizabeth T. Stark -- A Case Study In Drug Repositioning : Sosei / Akinori Mochizuki And Makiko Aoyama. Edited By Michael J. Barratt, Donald E. Frail. Includes Bibliographical References And Index.


๐Ÿ“œ SIMILAR VOLUMES


Drug Repositioning (Bringing New Life to
โœ Barratt, Michael J.; Frail, Donald E. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley & Sons, Inc. ๐ŸŒ English โš– 47 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to
โœ Barratt, Michael J.; Frail, Donald E. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley & Sons, Inc. ๐ŸŒ English โš– 175 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to
โœ Barratt, Michael J.; Frail, Donald E. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley & Sons, Inc. ๐ŸŒ English โš– 625 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to
โœ Barratt, Michael J.; Frail, Donald E. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley & Sons, Inc. ๐ŸŒ English โš– 292 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to
โœ Barratt, Michael J.; Frail, Donald E. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley & Sons, Inc. ๐ŸŒ English โš– 76 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.